Conduct Phase III CT: CDSCO Panel Tells Zydus Healthcare on FDC Dextromethorphan, Phenylephrine Syrup Dr. Divya Colin20 Dec 2024 6:00 PM ISTNew Delhi: Reviewing the justification for the Phase III clinical trial of Zydus Healthcare's fixed dose combination (FDC) pulmonary drug...
Alembic Pharma bags USFDA nod for anti-epileptic drug Ruchika Sharma20 Dec 2024 4:00 PM ISTVadodara: Alembic Pharmaceuticals Limited has announced that it has received Final Approval from the US Food & Drug Administration (USFDA)...
SPARC enters pact with University of California, San Francisco, Tiller Therapeutics for Pre-clinical Oncology asset Ruchika Sharma20 Dec 2024 1:30 PM ISTMumbai: Sun Pharma Advanced Research Company Ltd. (SPARC) has announced the signing of a binding Letter of Intent (LOI) with the University of...
Supriya Lifescience inaugurates Rs 125 crore API production block at Lote Parshuram site Ruchika Sharma20 Dec 2024 12:30 PM ISTMumbai: Supriya Lifescience Ltd has inaugurated its new multipurpose Active Pharmaceutical Ingredients (APIs) production block, Module E, at the...
Merck, Hansoh Pharma ink pact for oral small molecule GLP-1 receptor agonist Ruchika Sharma20 Dec 2024 11:30 AM ISTRahway: Merck, known as MSD outside of the United States and Canada, and Hansoh Pharma, a Chinese biopharmaceutical company, have announced that...
Indian pharma market for FY 2023-24 valued at USD 50 billion: MoS informs Rajya Sabha Ruchika Sharma19 Dec 2024 3:42 PM ISTNew Delhi: India's pharmaceutical market for FY 2023-24 is valued at USD 50 billion with domestic consumption valued at USD 23.5 billion and export...
Zydus Lifesciences wins USFDA nod to manufacture Lidocaine, Prilocaine Cream Ruchika Sharma19 Dec 2024 3:01 PM ISTAhmedabad: Zydus Lifesciences Limited has received final approval from the United States Food and Drug Administration (USFDA) to manufacture...
Gilead Sciences earns USFDA Breakthrough Therapy Designation for lung cancer treatment Trodelvy Ruchika Sharma19 Dec 2024 1:30 PM ISTFoster City: Gilead Sciences, Inc. has announced that Trodelvy (sacituzumab govitecan-hziy) has received Breakthrough Therapy...
JnJ seeks USFDA approval for Simponi to treat pediatric ulcerative colitis Ruchika Sharma19 Dec 2024 12:42 PM ISTDeveloped by Johnson & Johnson, SIMPONI is an anti-TNF biologic medicine that targets and blocks a protein called TNF-alpha.
Merck application for RSV treatment Clesrovimab for infants accepted by USFDA Ruchika Sharma19 Dec 2024 11:30 AM ISTRahway: Merck, known as MSD outside of the United States and Canada, has announced the U.S. Food and Drug Administration (FDA) has accepted...
USFDA approves Lupin drug for HIV-1 infection Ruchika Sharma18 Dec 2024 5:11 PM ISTMumbai: Global pharma major Lupin Limited today announced that it has received approval from the United States Food and Drug Administration (U.S. FDA)...
Merck discontinues clinical development programs for vibostolimab, favezelimab Ruchika Sharma18 Dec 2024 3:30 PM ISTRahway: Merck, known as MSD outside of the United States and Canada, has announced the discontinuation of the clinical development programs for...
